American International Group’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,517
| Closed | -$31.7K | – | 1451 |
|
|
2024
Q1 | $31.7K | Sell |
3,517
-30
| -0.8% | -$270 | ﹤0.01% | 2873 |
|
|
2023
Q4 | $33.6K | Sell |
3,547
-15
| -0.4% | -$142 | ﹤0.01% | 2895 |
|
|
2023
Q3 | $42.4K | Buy |
3,562
+127
| +4% | +$1.51K | ﹤0.01% | 2856 |
|
|
2023
Q2 | $84.2K | Buy |
3,435
+894
| +35% | +$21.9K | ﹤0.01% | 2686 |
|
|
2023
Q1 | $79.5K | Buy |
2,541
+51
| +2% | +$1.6K | ﹤0.01% | 2556 |
|
|
2022
Q4 | $175K | Sell |
2,490
-9
| -0.4% | -$634 | ﹤0.01% | 2193 |
|
|
2022
Q3 | $215K | Buy |
2,499
+322
| +15% | +$27.7K | ﹤0.01% | 2112 |
|
|
2022
Q2 | $180K | Buy |
2,177
+297
| +16% | +$24.6K | ﹤0.01% | 2259 |
|
|
2022
Q1 | $312K | Buy |
1,880
+21
| +1% | +$3.49K | ﹤0.01% | 1984 |
|
|
2021
Q4 | $311K | Sell |
1,859
-14
| -0.7% | -$2.34K | ﹤0.01% | 2092 |
|
|
2021
Q3 | $162K | Sell |
1,873
-45
| -2% | -$3.89K | ﹤0.01% | 2556 |
|
|
2021
Q2 | $104 | Buy |
1,918
+94
| +5% | +$5 | ﹤0.01% | 2866 |
|
|
2021
Q1 | $109 | Buy |
1,824
+4
| +0.2% | – | ﹤0.01% | 2671 |
|
|
2020
Q4 | $95 | Sell |
1,820
-52
| -3% | -$3 | ﹤0.01% | 2686 |
|
|
2020
Q3 | $91K | Buy |
1,872
+292
| +18% | +$14.2K | ﹤0.01% | 2578 |
|
|
2020
Q2 | $82K | Sell |
1,580
-255
| -14% | -$13.2K | ﹤0.01% | 2651 |
|
|
2020
Q1 | $80K | Buy |
1,835
+861
| +88% | +$37.5K | ﹤0.01% | 2443 |
|
|
2019
Q4 | $39K | Sell |
974
-8
| -0.8% | -$320 | ﹤0.01% | 2936 |
|
|
2019
Q3 | $32K | Sell |
982
-7
| -0.7% | -$228 | ﹤0.01% | 2976 |
|
|
2019
Q2 | $76K | Buy |
989
+186
| +23% | +$14.3K | ﹤0.01% | 2813 |
|
|
2019
Q1 | $142K | Buy |
803
+464
| +137% | +$82.1K | ﹤0.01% | 2408 |
|
|
2018
Q4 | $80K | Sell |
339
-3
| -0.9% | -$708 | ﹤0.01% | 2705 |
|
|
2018
Q3 | $73K | Buy |
+342
| New | +$73K | ﹤0.01% | 2959 |
|